Does Pegasys Cause Hair Thinning?
Yes, hair thinning or hair loss (alopecia) is a reported side effect of Pegasys (peginterferon alfa-2a), an antiviral medication used for hepatitis B and C. Clinical trials and post-marketing data show it affects 10-25% of patients, typically as diffuse thinning rather than complete baldness. It often starts 2-3 months into treatment and may reverse 3-6 months after stopping.[1][2]
How Common Is It Compared to Other Interferon Treatments?
Pegasys causes hair thinning less frequently than older interferons like standard interferon alfa (up to 40% incidence), but more than ribavirin alone (under 5%). Combination therapy with ribavirin raises the rate to 20-30%.[1][3]
Why Does It Happen?
Interferons like Pegasys trigger immune responses that disrupt the hair growth cycle, pushing follicles into a resting (telogen) phase. Stress from the drug's flu-like symptoms and anemia can worsen it. It's not permanent in most cases.[2][4]
What Do Patients Report?
User reviews on forums and FDA adverse event reports describe mild to moderate thinning, especially on the scalp, with some noting eyebrow or body hair loss. Women report it more often, but it resolves for 80-90% post-treatment.[1][5]
Can You Prevent or Manage Hair Thinning on Pegasys?
No proven prevention exists, but options include:
- Minoxidil (topical) to stimulate growth, started early.
- Dose reduction if severe, though this risks treatment failure.
- Supplements like biotin or iron if deficient, but evidence is weak.
Consult a doctor before changes; hair regrows naturally for most.[2][3]
When Does It Stop and Grow Back?
Thinning peaks mid-treatment and stabilizes. Regrowth begins 1-3 months after completion, full recovery in 6-12 months. Persistent cases (under 5%) may need dermatologist evaluation for scarring alopecia.[4]
Sources
[1] Pegasys Prescribing Information (FDA)
[2] Hepatitis C Online - Side Effects
[3] DrugPatentWatch.com - Pegasys Side Effects
[4] Journal of Clinical Gastroenterology - Interferon Alopecia
[5] FDA FAERS Database Summary